MET and adenocarcinoma: While some groups investigated a rather small group of patients [55–57], other groups found a negative prognostic effect of high MET protein expression and MET gene copy number gain either independent of the histologic type[58–63] or only in patients with adenocarcinoma[64] or squamous cell carcinoma[65].